| scholarly article | Q13442814 |
| P50 | author | Fred C Tenover | Q106114447 |
| Linda K. McDougal | Q115867930 | ||
| Sigrid K McAllister | Q115867942 | ||
| George E Killgore | Q115867944 | ||
| P2093 | author name string | Linda M Weigel | |
| Peter C Appelbaum | |||
| Bülent Bozdogan | |||
| Jean B Patel | |||
| Caroline M O'Hara | |||
| Jasmine Chaitram | |||
| Laura Jevitt | |||
| Nancye Clark | |||
| P2860 | cites work | Staphylococcus aureus infections | Q28131787 |
| Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing | Q29614699 | ||
| Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know | Q31704853 | ||
| Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides | Q33661713 | ||
| Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group | Q33852247 | ||
| Vancomycin-intermediate Staphylococcus aureus in Korea. | Q33970102 | ||
| Detection of the high-level aminoglycoside resistance gene aph(2")-Ib in Enterococcus faecium | Q33980844 | ||
| Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene | Q34188059 | ||
| Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance | Q34547868 | ||
| Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. | Q34968575 | ||
| Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus | Q35139457 | ||
| Gene heterogeneity for tetracycline resistance in Staphylococcus spp. | Q35270656 | ||
| Relatedness of tetracycline resistance plasmids among species of coagulase-negative staphylococci | Q35569761 | ||
| Characterization of glycopeptide-resistant enterococci from U.S. hospitals | Q35899762 | ||
| Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. | Q35965824 | ||
| Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. | Q36516947 | ||
| Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. | Q36519254 | ||
| Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR | Q36525712 | ||
| Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database | Q37059039 | ||
| Phylogenetic relationship of the twenty-one DNA groups of the genus Acinetobacter as revealed by 16S ribosomal DNA sequence analysis | Q38557062 | ||
| Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. | Q39474811 | ||
| Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256 | Q39814923 | ||
| Nucleotide sequence of the Staphylococcus aureus gyrB-gyrA locus encoding the DNA gyrase A and B proteins | Q39936506 | ||
| Recommendations for preventing the spread of vancomycin resistance | Q40530998 | ||
| Resistance to glycopeptides in enterococci | Q41466280 | ||
| Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin | Q43754217 | ||
| Vancomycin-resistant Staphylococcus aureus--Pennsylvania, 2002. | Q44206422 | ||
| Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus | Q44453944 | ||
| Vancomycin-resistant Staphylococcus aureus: infection control considerations | Q45113221 | ||
| The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. | Q54105049 | ||
| Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. | Q54125099 | ||
| Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. | Q55067143 | ||
| Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium | Q70057223 | ||
| Interim guidelines for prevention and control of Staphylococcal infection associated with reduced susceptibility to vancomycin | Q73501090 | ||
| First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital | Q74716023 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| Staphylococcus aureus | Q188121 | ||
| vancomycin | Q424027 | ||
| P1104 | number of pages | 6 | |
| P304 | page(s) | 275-280 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania | |
| P478 | volume | 48 |
| Q34648847 | 7-O-malonyl macrolactin A, a new macrolactin antibiotic from Bacillus subtilis active against methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and a small-colony variant of Burkholderia cepacia |
| Q36083140 | A multi-center blinded study on the efficiency of phenotypic screening methods to detect glycopeptide intermediately susceptible Staphylococcus aureus (GISA) and heterogeneous GISA (h-GISA). |
| Q42912582 | A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides |
| Q46152812 | A new type of tripropeptin with anteiso-branched chain fatty acid from Lysobacter sp. BMK333-48F3. |
| Q37340283 | A rapid molecular method for characterising bacterial bioburden in chronic wounds |
| Q37277083 | Acquired vancomycin resistance in clinically relevant pathogens |
| Q42846052 | Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology |
| Q34566819 | Activity of retapamulin against Streptococcus pyogenes and Staphylococcus aureus evaluated by agar dilution, microdilution, E-test, and disk diffusion methodologies |
| Q38070154 | An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy |
| Q44814165 | Analysis of genetic diversity among Staphylococcus aureus isolates from patients with deep-seated and superficial staphylococcal infections using pulsed-field gel electrophoresis |
| Q94545259 | Anthracycline Shunt Metabolites From Philippine Marine Sediment-Derived Streptomyces Destroy Cell Membrane Integrity of Multidrug-Resistant Staphylococcus aureus |
| Q29620008 | Antibacterial resistance worldwide: causes, challenges and responses |
| Q36283731 | Antibiotic resistance in Staphylococcus aureus and its relevance in therapy |
| Q36325685 | Antimicrobial agents for treatment of serious infections caused by resistant Staphylococcus aureus and enterococci |
| Q35859951 | Antimicrobial stewardship programs as a means to optimize antimicrobial use. Insights from the Society of Infectious Diseases Pharmacists |
| Q40335240 | Antistaphylococcal activities of telavancin tested alone and in combination by time-kill assay |
| Q40336352 | Antistaphylococcal activity of ACHN-490 tested alone and in combination with other agents by time-kill assay |
| Q37568895 | Antistaphylococcal activity of CB-181963 (CAB-175), an experimental parenteral cephalosporin |
| Q41991673 | Antistaphylococcal activity of CG400549, a new experimental FabI inhibitor, compared with that of other agents |
| Q42070285 | Antistaphylococcal activity of DX-619 alone and in combination with vancomycin, teicoplanin, and linezolid assessed by time-kill synergy testing |
| Q41816467 | Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents. |
| Q40165422 | Antistaphylococcal activity of LBM415, a new peptide deformylase inhibitor, compared with those of other agents |
| Q41847350 | Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin |
| Q31004673 | Are we ready for novel detection methods to treat respiratory pathogens in hospital-acquired pneumonia? |
| Q34372304 | AsrR is an oxidative stress sensing regulator modulating Enterococcus faecium opportunistic traits, antimicrobial resistance, and pathogenicity. |
| Q84275307 | Cellular effects induced by Inula graveolens and Santolina corsica essential oils on Staphylococcus aureus |
| Q42080637 | Characterization of vancomycin-resistant Enterococcus faecium isolates from broiler poultry and pig farms in England and Wales. |
| Q24634085 | Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study |
| Q36292288 | Clinical significance of emergence of bacterial antimicrobial resistance in the hospital environment |
| Q36070903 | Community-associated methicillin-resistant Staphylococcus aureus: a review |
| Q33699183 | Comparative genomics of Staphylococcus aureus musculoskeletal isolates. |
| Q36025858 | Comparative genomics of vancomycin-resistant Staphylococcus aureus strains and their positions within the clade most commonly associated with Methicillin-resistant S. aureus hospital-acquired infection in the United States |
| Q40734214 | Comparison of Tn1546-like elements in vancomycin-resistant Staphylococcus aureus isolates from Michigan and Pennsylvania |
| Q35745242 | Confronting bacterial resistance in healthcare settings: a crucial role for microbiologists |
| Q24674841 | Dalbavancin: a novel antimicrobial |
| Q36003721 | Daptomycin: a cyclic lipopeptide antimicrobial agent |
| Q36161246 | Defining the need for new antimicrobials: clinical and economic implications of resistance in the hospitalised patient |
| Q37625160 | Derivatives of a vancomycin-resistant Staphylococcus aureus strain isolated at Hershey Medical Center. |
| Q35755621 | Detection of Antibiotic Resistant Staphylococcus aureus from Milk: A Public Health Implication |
| Q40772718 | Detection of methicillin-resistant Staphylococcus pseudintermedius ST169 and novel ST354 SCCmec II-III isolates related to the worldwide ST71 clone |
| Q40626087 | Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCR. |
| Q34352287 | Diagnostic PCR analysis of the occurrence of methicillin and tetracycline resistance genes among Staphylococcus aureus isolates from phase 3 clinical trials of tigecycline for complicated skin and skin structure infections |
| Q43714636 | Distribution of antimicrobial-resistant lactic acid bacteria in natural cheese in Japan |
| Q41559217 | Double-disk synergy test for detection of synergistic effect between antibiotics against nosocomial strains of staphylococcus aureus |
| Q40260354 | Effects of Mesua ferrea leaf and fruit extracts on growth and morphology of Staphylococcus aureus |
| Q52682677 | Efficiency of different control measures for preventing carbapenemase-producing enterobacteria and glycopeptide-resistant Enterococcus faecium outbreaks: a 6-year prospective study in a French multihospital institution, January 2010 to December 2015 |
| Q28238173 | Enterococci and streptococci |
| Q40799074 | Enterotoxigenic and antibiotic resistance determination of Staphylococcus aureus strains isolated from food handlers in Gaborone, Botswana |
| Q42123186 | Evaluation of a new chromogenic medium, ChromID VRE, for detection of vancomycin-resistant Enterococci in stool samples and rectal swabs |
| Q33221616 | Evaluation of non-automated techniques for phenotypic detection of VanA-type Staphylococcus aureus |
| Q30230055 | Evaluation of the AdvanDx VRE EVIGENE assay for detection of vanA in vancomycin-resistant Staphylococcus aureus |
| Q24685170 | Experimental phage therapy against Staphylococcus aureus in mice |
| Q40771872 | First report of vancomycin-resistant staphylococci isolated from healthy carriers in Brazil |
| Q35073589 | Genetic background and antibiotic resistance of Staphylococcus aureus strains isolated in the Republic of Georgia |
| Q39561287 | Genetic characterization of a vancomycin-resistant Staphylococcus aureus isolate from the respiratory tract of a patient in a university hospital in northeastern Iran |
| Q33898586 | Genome-wide dynamics of a bacterial response to antibiotics that target the cell envelope |
| Q36073633 | Genomic analysis of the emergence of vancomycin-resistant Staphylococcus aureus |
| Q36009410 | Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex |
| Q24241924 | Gloves, gowns and masks for reducing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in the hospital setting |
| Q35752864 | Glycopeptide antibiotics: from conventional molecules to new derivatives |
| Q35938608 | Glycopeptide resistant Staphylococcus |
| Q36188333 | Gram-positive resistance: pathogens, implications, and treatment options: insights from the Society of Infectious Diseases Pharmacists |
| Q36315377 | Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). |
| Q36763637 | Health care-associated native valve endocarditis: importance of non-nosocomial acquisition |
| Q40290802 | Heterologous expression of the enterococcal vanA operon in methicillin-resistant Staphylococcus aureus |
| Q34577836 | High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm |
| Q37007474 | Hyaluronidase expression and biofilm involvement in Staphylococcus aureus UAMS-1 and its sarA, agr and sarA agr regulatory mutants |
| Q34666376 | Iclaprim |
| Q34510589 | Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model |
| Q34538516 | Improved precursor-directed biosynthesis in E. coli via directed evolution. |
| Q41832542 | In vitro 24-hour time-kill studies of vancomycin and linezolid in combination versus methicillin-resistant Staphylococcus aureus |
| Q37144800 | In vitro activity of Iclaprim against respiratory and bacteremic isolates of Streptococcus pneumoniae |
| Q31126282 | In vitro and in vivo activities of antibiotic PM181104. |
| Q42112686 | In vitro antibacterial activity of DX-619, a novel des-fluoro(6) quinolone |
| Q46867668 | In vitro antimicrobial activity of telavancin against methicillin-resistant Staphylococcus aureus clinical isolates from Japan (2006). |
| Q41387835 | Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical Center |
| Q64055509 | Indocyanine Green-Mediated Photodynamic Therapy Reduces Methicillin-Resistant Drug Resistance |
| Q37600393 | Infections caused by Gram-positive bacteria: a review of the global challenge |
| Q33270515 | Insertion sequence-driven diversification creates a globally dispersed emerging multiresistant subspecies of E. faecium |
| Q36425109 | Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery |
| Q37072798 | LysGH15 kills Staphylococcus aureus without being affected by the humoral immune response or inducing inflammation |
| Q34487554 | LysGH15, a Novel Bacteriophage Lysin, Protects a Murine Bacteremia Model Efficiently against Lethal Methicillin-Resistant Staphylococcus aureus Infection |
| Q34657311 | Mechanisms of antibiotic resistance in Staphylococcus aureus |
| Q36006718 | Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci co-colonization |
| Q37214008 | Methicillin-resistant Staphylococcus aureus in Spain: molecular epidemiology and utility of different typing methods |
| Q36328966 | Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains |
| Q37600385 | Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria |
| Q34089037 | Mobile genetic elements of Staphylococcus aureus |
| Q38474869 | Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates |
| Q43508995 | Nasal carriage of pathogenic bacteria in medical students: effects of clinic exposure on prevalence and antibiotic susceptibility. |
| Q40149893 | Novel targets for antibiotics in Staphylococcus aureus |
| Q46454571 | Pargamicin A, a novel cyclic peptide antibiotic from Amycolatopsis sp. |
| Q35785222 | Pharmacogenomic strategies against resistance development in microbial infections |
| Q37284356 | Pre-clinical experience with daptomycin |
| Q42252345 | Prevalence and risk factors associated with vancomycin-resistant Staphylococcus aureus precursor organism colonization among patients with chronic lower-extremity wounds in Southeastern Michigan. |
| Q34315951 | Prevalence, persistence, and molecular characterization of glycopeptide-resistant enterococci in Norwegian poultry and poultry farmers 3 to 8 years after the ban on avoparcin |
| Q37546679 | Rapid detection of Staphylococcus aureus strains with reduced susceptibility to vancomycin by isothermal microcalorimetry |
| Q46172530 | Recovery of both vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus from culture of a single clinical specimen from colonized or infected patients |
| Q36804431 | Relative quantitative comparisons of the extracellular protein profiles of Staphylococcus aureus UAMS-1 and its sarA, agr, and sarA agr regulatory mutants using one-dimensional polyacrylamide gel electrophoresis and nanocapillary liquid chromatograp |
| Q36505478 | Role of linezolid in the treatment of complicated skin and soft tissue infections |
| Q35586461 | Semi-synthetic glycopeptide antibacterials |
| Q42593941 | Sensitivity and specificity of a rapid rRNA gene probe assay for simultaneous identification of Staphylococcus aureus and detection of mecA. |
| Q44536874 | Staphylococcus aureus nasal carriage in a student community: prevalence, clonal relationships, and risk factors |
| Q35882353 | Staphylococcus aureus with reduced susceptibility to vancomycin |
| Q90047949 | Strain- and Species-Level Variation in the Microbiome of Diabetic Wounds Is Associated with Clinical Outcomes and Therapeutic Efficacy |
| Q34042156 | Successful multiresistant community-associated methicillin-resistant Staphylococcus aureus lineage from Taipei, Taiwan, that carries either the novel Staphylococcal chromosome cassette mec (SCCmec) type VT or SCCmec type IV. |
| Q42001450 | Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics |
| Q39077455 | Synergism between beta-lactams and glycopeptides against VanA-type methicillin-resistant Staphylococcus aureus and heterologous expression of the vanA operon |
| Q58570534 | Synergistic Effect of Combinations Containing EDTA and the Antimicrobial Peptide AA230, an Arenicin-3 Derivative, on Gram-Negative Bacteria |
| Q37323867 | Synergy of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus aureus. |
| Q33486457 | Synthesis and combinational antibacterial study of 5''-modified neomycin. |
| Q29544028 | The antibiotic resistome: the nexus of chemical and genetic diversity |
| Q27013003 | The multifaceted resources and microevolution of the successful human and animal pathogen methicillin-resistant Staphylococcus aureus |
| Q35585561 | The photodynamic antibacterial effects of silicon phthalocyanine (Pc) 4 |
| Q36779557 | The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus |
| Q38332457 | The role of the novel Fem protein VanK in vancomycin resistance in Streptomyces coelicolor |
| Q46899374 | The vancomycin resistance VanRS two-component signal transduction system of Streptomyces coelicolor. |
| Q28253736 | Tigecycline: first of a new class of antimicrobial agents |
| Q36758570 | Treatment of Staphylococcus aureus infections: new issues, emerging therapies and future directions |
| Q39181004 | Two Dimensional Structural Analysis and Expression of a New Staphylococcus aureus Adhesin Based Fusion Protein |
| Q41818060 | Use of a multiplex molecular beacon platform for rapid detection of methicillin and vancomycin resistance in Staphylococcus aureus |
| Q37511373 | VanA-type vancomycin-resistant Staphylococcus aureus |
| Q28284820 | Vancomycin resistance in gram-positive cocci |
| Q63762325 | Vancomycin-resistance Transferability from VanA Enterococci to Staphylococcus aureus |
| Q46766488 | Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. |
| Q41915203 | Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan |
| Q35682424 | Virulence and antimicrobial resistance factors of Enterococcusspp. isolated from fecal samples from piggery farms in Eastern Cape, South Africa |
| Q59340679 | Whole-genome epidemiology, characterisation, and phylogenetic reconstruction of Staphylococcus aureus strains in a paediatric hospital |
| Q53875853 | [Do glycopeptides remain the preferred treatment of nosocomial infections from multidrug resistant Staphylococcus?] |
| Q45930371 | [Interventions implemented to control an outbreak of vancomycin-resistant enterococci in a university hospital]. |
Search more.